Denosumab for management of parathyroid carcinoma-mediated hypercalcemia.

Vellanki, Priyathama

Denosumab for management of parathyroid carcinoma-mediated hypercalcemia. [electronic resource] - The Journal of clinical endocrinology and metabolism Feb 2014 - 387-90 p. digital

Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural

1945-7197

10.1210/jc.2013-3031 doi


Adult
Antibodies, Monoclonal, Humanized--therapeutic use
Carcinoma--complications
Denosumab
Humans
Hypercalcemia--drug therapy
Male
Parathyroid Neoplasms--complications
Treatment Outcome